Developing helical peptide therapeutics for undruggable cancer targets.
| Title |
|---|
| Senior Manager, Supply Chain Full Time · $153K-$180K · 5+ YOE Cambridge, Massachusetts, United States · Onsite |
| Senior Associate Scientist, Biology Full Time · $88K-$108K · 4+ YOE Cambridge, Massachusetts, United States · Onsite |
| Director, Intellectual Property (Patent Agent or Patent Attorney) Full Time · $220K-$290K · 5+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Associate Director, Pharmacology Full Time · $165K-$200K · 8+ YOE Cambridge, Massachusetts, United States · Onsite |
| Senior Data Scientist, Computational Chemistry Full Time · $145K-$175K · 5+ YOE Cambridge, Massachusetts, United States · Onsite |
| Associate Director, Data Science, Computational Biology Full Time · $175K-$220K · 7+ YOE Cambridge, Massachusetts, United States · Onsite |
| Associate Director, Medicinal Chemistry - Synthesis Full Time · $165K-$200K · 8+ YOE Cambridge, Massachusetts, United States · Onsite |
| Scientist I, Peptide Drug Discovery Full Time · $110K-$125K · 0+ YOE Cambridge, Massachusetts, United States · Onsite |
| Senior Data Scientist - Chemical / Peptide Sciences Full Time · $145K-$175K · 5+ YOE Cambridge, Massachusetts, United States · Onsite |
| Research Equipment Lead Full Time · $86K-$110K Cambridge, Massachusetts, United States · Onsite |
| Vice President, Biometry Full Time · 15+ YOE Cambridge, Massachusetts, United States · Hybrid |
| Senior Director, Clinical Pharmacology & Pharmacometrics Full Time · $250K-$300K · 12+ YOE United States · Remote |
| Activities | Peptide drug discoveryClinical oncology developmentIntracellular protein modulationPrecision medicine researchTargeted therapy development |
| Headquarters | US |
| Industries | BiotechnologyPharmaceuticals |
| Name | Parabilis Medicines |
| Employees | 176 |
| Type | Private |
| Tagline | Developing helical peptide therapeutics for undruggable cancer targets. |
| Founded | 2,015 |
| Website | parabilismed.com |
| Latest Funding Round | Series F |
| Latest Funding Year | 2,026 |
| Latest Funding Amount | 305,000,000 |
| Latest Investors | RA Capital ManagementFidelity Management & ResearchJanus Henderson Investors |